BeyondSpring Inc. received a written notification from Nasdaq on September 29, 2026, stating it no longer complies with the Market Value of Listed Securities (MVLS) requirement because its MVLS fell below $35 million for 30 consecutive business days. The company has an 180-day compliance period until March 29, 2027, to restore its MVLS to at least $35 million for ten consecutive business days. Failure to regain compliance by the deadline will result in a delisting notification, though the company may appeal. This event poses significant risk to the company's listing status and liquidity but does not immediately affect operations or trading. BeyondSpring Inc. operates in the biopharmaceutical industry, focusing on the development of cancer treatments.
